Mechanism of apoptosis induced by Paclitaxel combined with TRAIL in the MCF-7 breast cancer cell line
Tong Zhong-shen
Abstract
Tong Zhong-shen
Abstract
Objective To determine the interaction between Paclitaxel and TRAIL(tumor necrosis factor-related apoptosis inducing ligand) in MCF-7 breast cancer cell line and investigate the possible mechanism.Methods The inhibitory rates of different concentrations of Paclitaxel,TRAIL alone or different combinations of Paclitaxel and TRAIL on MCF-7 cells were examined by MTT assay.MCF-7 cells of the control group,the TRAIL group,the Paclitaxel group and the combination group were stained by Annexin V-FITC/PI;and the apoptosis rates were detected by flow cytometry.At mRNA levels,DR4 and DR5 of MCF-7 cells treated by Paclitaxel were semi-qualified by RT-PCR.Results MTT assay showed that MCF-7 cells were sensitive to Paclitaxel in a dose-dependent manner and less sensitive to TRAIL.MTT assay also showed different combination schemes had different inhibitory effects.There were not synergistic effects in Sheme 1(MCF-7 cells were treated by Paxlitaxel and TRAIL simultaneously,CDI=1.00,0.85) and Sheme 2(MCF-7 cells were treated with TRAIL firstly and successively treated with Paclitaxel,CDI=0.87,0.85),but synergistic effects could be seen in Sheme 3(MCF-7 cells treated with Paclitaxel firstly and successively treated with TRAIL,CDI=0.46,0.75)).The synergism of Sheme 3 was verified by Annexin V-FITC/PI assay.DR4 and DR5 were detected by RT-PCR at mRNA levels,DR5 was up-regulated by Paclitaxel,but DR4 was not changed significantly.Conclusions A synergism could be seen when MCF-7 cells were treated with Paclitaxel followed by TRAIL,the mechanism of which may be related to the up-regulation of DR5 induced by Paclitaxel at the mRNA level.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To determine the interaction between Paclitaxel and TRAIL(tumor necrosis factor-related apoptosis inducing ligand) in MCF-7 breast cancer cell line and investigate the possible mechanism.Methods The inhibitory rates of different concentrations of Paclitaxel,TRAIL alone or different combinations of Paclitaxel and TRAIL on MCF-7 cells were examined by MTT assay.MCF-7 cells of the control group,the TRAIL group,the Paclitaxel group and the combination group were stained by Annexin V-FITC/PI;and the apoptosis rates were detected by flow cytometry.At mRNA levels,DR4 and DR5 of MCF-7 cells treated by Paclitaxel were semi-qualified by RT-PCR.Results MTT assay showed that MCF-7 cells were sensitive to Paclitaxel in a dose-dependent manner and less sensitive to TRAIL.MTT assay also showed different combination schemes had different inhibitory effects.There were not synergistic effects in Sheme 1(MCF-7 cells were treated by Paxlitaxel and TRAIL simultaneously,CDI=1.00,0.85) and Sheme 2(MCF-7 cells were treated with TRAIL firstly and successively treated with Paclitaxel,CDI=0.87,0.85),but synergistic effects could be seen in Sheme 3(MCF-7 cells treated with Paclitaxel firstly and successively treated with TRAIL,CDI=0.46,0.75)).The synergism of Sheme 3 was verified by Annexin V-FITC/PI assay.DR4 and DR5 were detected by RT-PCR at mRNA levels,DR5 was up-regulated by Paclitaxel,but DR4 was not changed significantly.Conclusions A synergism could be seen when MCF-7 cells were treated with Paclitaxel followed by TRAIL,the mechanism of which may be related to the up-regulation of DR5 induced by Paclitaxel at the mRNA level.
Key concepts: Paclitaxel, MCF-7, MTT assay, Apoptosis, Annexin, Chemistry, Flow cytometry, Cancer cell